Cargando…
Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers
A diagnosis of pancreatic cancer is devastating owing to its poor prognosis, with a 5-year survival rate of only 9%. Currently, most individuals are diagnosed at a late stage when treatment options are limited. Early detection of pancreatic cancer provides the greatest hope for making substantial im...
Autores principales: | Kenner, Barbara J., Go, Vay Liang W., Chari, Suresh T., Goldberg, Ann E., Rothschild, Laura J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647107/ https://www.ncbi.nlm.nih.gov/pubmed/28953187 http://dx.doi.org/10.1097/MPA.0000000000000939 |
Ejemplares similares
-
Early Detection of Pancreatic Cancer—a Defined Future Using Lessons From Other Cancers: A White Paper
por: Kenner, Barbara J., et al.
Publicado: (2016) -
Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper
por: Kenner, Barbara J., et al.
Publicado: (2015) -
Early Detection of Pancreatic Cancer: Applying Artificial Intelligence to Electronic Health Records
por: Kenner, Barbara J., et al.
Publicado: (2021) -
Inaugural Meeting of North American Pancreatic Cancer Organizations: Advancing Collaboration and Communication
por: Kenner, Barbara J., et al.
Publicado: (2015) -
Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review
por: Kenner, Barbara, et al.
Publicado: (2021)